Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland

被引：0

作者：

Ewa Stawowczyk

Paweł Kawalec

Andrzej Pilc

机构：

[1] StatSoft Polska Sp. z o.o.,Department of Drug Management, Institute of Public Health, Faculty of Health Sciences

[2] Jagiellonian University Medical College,Department of Neurobiology

[3] Institute of Pharmacology,undefined

[4] Polish Academy of Sciences,undefined

来源：

European Journal of Clinical Pharmacology | 2016年 / 72卷

关键词：

Ulcerative colitis; Cost-utility; Adalimumab; Economic analysis; Indirect costs;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1319 / 1325

页数：6

共 48 条